Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 8 Breast Neoplasms 8 Neoplasms 7 Depression 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Anxiety Disorders 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Prostatic Hyperplasia 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell, Marginal Zone 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Fatigue 2

Interventions

Aminolevulinic Acid 5 Fluorouracil 3 tirbanibulin 2 Photochemotherapy 2 Niacinamide 2 Cryotherapy 2 methyl 5-aminolevulinate 1 green tea extract polyphenone E 1 dehydroftorafur 1 calcipotriene 1 Therapeutics 1 Sunscreening Agents 1 Powders 1 Ointments 1 Imipramine 1 Control Groups 1 Biopsy 1 BF-200 ALA 1 Aluminum Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Keratosis, Actinic × Therapeutics × 1 year × Clear all

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡